DBP, and PP categories and helps identify subjects at the highest risk. Participants with stage 1 hypertension but elevated NT-proBNP had greater cardiovascular risk compared with those with stage 2 SBP but lower NT-proBNP. ...
Information on how the SEM analyses were constructed, with information on the number of individuals with cognitive and brain imaging measures at each Wave, is included in Supplementary Information. Basic models were run with adjustment for age and sex, whereas fully adjusted models included further ...
Best practice for LDL-cholesterol: when and how to calculate. J Clin Pathol. 2023;76(3):145–52. Article CAS PubMed Google Scholar Visseren FLJ, Mach F, Smulders YM, Carballo D, Koskinas KC, Bäck M, et al. 2021 ESC guidelines on cardiovascular disease prevention in clinical practice...
How to get tested Your doctor will decide if BNP or NT-proBNP testing is appropriate in your situation. The test is usually done in a hospital and frequently is performed in the emergency room. The test can also be done in a doctor’s office or outpatient laboratory or clinic. ...
how baseline NT-proBNP and the H2FPEF score influenced empagliflozin-associated left ventricular (LV) remodeling in people with either type 2 diabetes and coronary artery disease or without diabetes but with cardiovascular risk factors.#Methods:A total of 242 participants were assigned to either ...
Thus, there is a need for clinical studies to evaluate the possible differences in clinical accuracy among different NT-proBNP methods when only a cut-off value is used in clinical practice for ruling out patients with suspected HF. The scope could be further extended by investigating how the ...
Results: A comparison of the three samples showed that NT-proBNP concentrations in the rugby players were lower than those in controls at rest and were similar to those in professional soccer players. Elevated post-training NT-proBNP levels were unaffected by the type of recovery. The relatively...
How to image cardiac amyloidosis. Circ Cardiovasc Imaging 2014; 7: 552–562. 61 Fontana M, Chung R, Hawkins PN, Moon JC. Cardiovascular magnetic resonance for amyloidosis. Heart Fail Rev 2015; 20: 133–144. 62 Dispenzieri A, Gertz MA, Kumar SK, Lacy MQ, Kyle RA, Saenger AK et al...
susenvironmentininflammatoryhoweldisease:resultofa Britishtwinstudy[J].BMJ,1996,312(7023):95～96. [20] VermeireS.Reviewarticle:geneticsusceptibilityandappli cationofgenetictestinginclinicalmanagementofinflam matoryboweldisease[J].AlimentPharmacolTher,2006, ...
For instance, no detailed information were provided about how comorbidities were identified and how severe they were. Moreover, only two-third patients had data available about echocardiography, which made HF diagnosis uncertain in a subset of database. Conclusion In a HF population ≥ 75 years ...